UNSPSC 51422210: Triamcinolone acetonide

This classification denotes a therapeutic glucocorticoid with the molecular formula C24H31FO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F446C597KA, chemically known as 9-fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone but more generally known as triamcinolone acetonide, which bears US NIH Compound Identifier 6436. European Medicines Agency schedules Triamcinolone acetonide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04936MIG.

UNSPSC 51422210 Triamcinolone acetonide is a Commodity code nominally covering a synthetic corticosteroid pharmaceutical, but recent state and local procurement activity tagged to this code does not reflect triamcinolone acetonide purchasing. Instead, the code shows isolated, unrelated pharmaceutical and pharmacy-benefit opportunities that do not substantively represent triamcinolone acetonide procurement at the state or local level. The recent opportunities include naloxone and drug deactivation systems procurement by a county health authority and a state-level exploratory request for information on direct-to-manufacturer pharmacy programs — neither of which involves triamcinolone acetonide or injectable corticosteroids as a product category.

The code shows minimal recent activity with no clear pattern of triamcinolone acetonide solicitation across state and local jurisdictions. One opportunity originates from Seminole County, Florida (IFB 60459723LAS, posted June 30, 2026, due July 26, 2023), which seeks naloxone and drug deactivation systems with quarterly deliveries; the other is a Request for Information from the Texas Health and Human Services Commission (RFI HHS0017013, posted April 3, 2026) exploring direct-to-manufacturer prescription program capabilities. The code's nominal scope and the actual procurement activity it has recently attracted do not align, suggesting either tagging inconsistency within the state and local databases or negligible current demand for triamcinolone acetonide as a standalone procurement line item in state or local purchasing.